Craig Titsch
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Biosimilars and Bioanalytical Methods, Advanced Biosensing Techniques and Applications, Metabolism and Genetic Disorders, Hepatitis C virus research
Most-Cited Works
- → SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models(2005)134 cited
- → Fully Validated LC-MS/MS Assay for the Simultaneous Quantitation of Coadministered Therapeutic Antibodies in Cynomolgus Monkey Serum(2013)84 cited
- → Innovative Use of LC-MS/MS for Simultaneous Quantitation of Neutralizing Antibody, Residual Drug, and Human Immunoglobulin G in Immunogenicity Assay Development(2014)45 cited
- → Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay(2012)40 cited
- → Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation(2015)32 cited
- → Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays(2014)29 cited
- → High-Throughput Therapeutic Antibody Interference-Free High-Resolution Mass Spectrometry Assay for Monitoring M-Proteins in Multiple Myeloma(2020)23 cited
- → An Exploratory Universal LC–MS/MS Assay for Bioanalysis of Hinge Region-Stabilized Human Igg4 Mabs in Clinical Studies(2014)23 cited
- → Singlicate Ligand Binding Assay Using an Automated Microfluidic System: a Clinical Case Study(2017)16 cited
- → Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach(2017)9 cited